Drugs / Depigoid(R)Birch 5000
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01694836 | Sep 2012 → Jul 2018 | allergic rhinitis, ragweed sensitivity | Leti Pharma GmbH | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Depigoid(R)Birch 5000 | “Long-term study to assess safety and efficacy of Depigoid(R)Birch 5000 - a modified pollen extract of Betula alba (Birch) - versus placebo.” NCT01694836 ↗ |
| Modality | Other / unclassified | “a modified pollen extract of Betula alba (Birch)” NCT01694836 ↗ |
| Route | Subcutaneous | “Suspension for s.c. injection.” NCT01694836 ↗ |